Сообщений в теме: 51

[CopperKettle]

"the CD4/CD8 ratio has emerged as a potential biomarker to predict how well someone with schizophrenia might respond to treatment" - new research

[CopperKettle]

This one is quite curious, I wonder if there have been any additional studies or if there are any planned studies of this:
 

Can Low-Dose Naltrexone Help Patients with Depression? (Psychiatric Times, 2020)

It's curious because it might turn out suitable for patients suffering from inflammation, although I can't tell this with any confidence - I only came across "low-dose naltrexone" (LND) today. I previously only knew of its use in treatment of opioid additiction and alcohol addiction.